<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="4999">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    https://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 13, 2016</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01184014</url>
  </required_header>
  <id_info>
    <org_study_id>04000-10-C</org_study_id>
    <nct_id>NCT01184014</nct_id>
  </id_info>
  <brief_title>Hospital Insulin Protocol Aims for Glucose Control in Corticosteroid-induced Hyperglycemia</brief_title>
  <official_title>Hospital Insulin Protocol Aims for Glucose Control in Corticosteroid-induced Hyperglycemia</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>HealthPartners Institute</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>International Diabetes Center at Park Nicollet</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Sanofi</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>HealthPartners Institute</source>
  <oversight_info>
    <authority>United States: Institutional Review Board</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The objective of this study is to determine the best insulin regimen for hospitalized
      patients who receive high doses of steroids who have high blood glucose.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The overall study objective of this research is to establish the efficacy and assure the
      safety of achieving glycemic control in hospitalized patients who receive greater than
      physiologic doses of steroids. This study will compare 2 methods of achieving glycemic
      control in hospitalized patients who develop steroid-induced hyperglycemia (blood glucose
      (BG) &gt;180 mg/dL): 1) a study-specific steroid NPH dosing algorithm plus standard recommended
      care (Experimental group) vs. 2) the standard recommended care (Methodist Hospital Complete
      Insulin Orders (Control group).
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>August 2010</start_date>
  <completion_date type="Actual">August 2012</completion_date>
  <primary_completion_date type="Actual">August 2012</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment</study_design>
  <primary_outcome>
    <measure>Mean Blood Glucose.</measure>
    <time_frame>discharge or until after their 5th day in the hospital</time_frame>
    <safety_issue>No</safety_issue>
    <description>as stated above</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>the Mean Blood Glucose of All Blood Glucose Readings</measure>
    <time_frame>starting 3 hours after the initial index BG&gt;180 measure, across the entire hospital stay or up through 5 days if hospital LOS is &gt; 5 days</time_frame>
    <safety_issue>No</safety_issue>
    <description>as stated above</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">72</enrollment>
  <condition>Hyperglycemia</condition>
  <arm_group>
    <arm_group_label>Experimental group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>a study-specific steroid NPH dosing algorithm plus standard recommended care</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>the standard recommended care (Methodist Hospital Complete Insulin Orders)</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>NPH insulin plus Complete Insulin Orders</intervention_name>
    <description>NPH dosed per study-specific algorithm which incorporates total daily dosage of steroid to determine NPH dose. Complete insulin orders include background, meal-time and correction factor.</description>
    <arm_group_label>Experimental group</arm_group_label>
    <other_name>lantus</other_name>
    <other_name>glargine</other_name>
    <other_name>humalog</other_name>
    <other_name>lispro</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Complete Insulin Orders</intervention_name>
    <description>3-part insulin which includes background, meal-time and correction factor</description>
    <arm_group_label>Control group</arm_group_label>
    <other_name>lantus</other_name>
    <other_name>glargine</other_name>
    <other_name>humalog</other_name>
    <other_name>lispro</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Men or women aged ≥18 years who receive steroids in doses greater than physiologic
             replacement levels of ≥ 10 mg Prednisone or its equivalent of dexamethasone or
             methylprednisolone.

          -  Have signed the consent form for the study

          -  Have a BG &gt; 180 mg/dL any time during the first 24 hour of steroid administration
             that is above physiological replacement ( ≥ 10 mg Prednisone or equivalent)

          -  Are scheduled to be in hospital ≥ 2 days.

        Exclusion Criteria:

          -  Unable to read or understand English

          -  History of psychiatric disability affecting informed consent or compliance with drug
             intake

          -  Type 1 diabetes

          -  Acute or chronic renal failure (creatinine clearance &lt;30mL/min estimated by method of
             Cockcroft and Gault)

          -  Patients in Hospice Care

          -  Age &lt;18 years

          -  Previously enrolled in this study.

          -  Not appropriate for the steroid protocol in judgment of the principal investigator
             and/or attending physician.
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Richard M Bergenstal, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>International Diabetes Center at Park Nicollet</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Park Nicollet Health Services Methodist Hospital</name>
      <address>
        <city>St. Louis Park</city>
        <state>Minnesota</state>
        <zip>55416</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Clore JN, Thurby-Hay L. Glucocorticoid-induced hyperglycemia. Endocr Pract. 2009 Jul-Aug;15(5):469-74. doi: 10.4158/EP08331.RAR. Review.</citation>
    <PMID>19454391</PMID>
  </reference>
  <reference>
    <citation>Derendorf H, Hochhaus G, Möllmann H, Barth J, Krieg M, Tunn S, Möllmann C. Receptor-based pharmacokinetic-pharmacodynamic analysis of corticosteroids. J Clin Pharmacol. 1993 Feb;33(2):115-23.</citation>
    <PMID>8440759</PMID>
  </reference>
  <reference>
    <citation>Donihi AC, Raval D, Saul M, Korytkowski MT, DeVita MA. Prevalence and predictors of corticosteroid-related hyperglycemia in hospitalized patients. Endocr Pract. 2006 Jul-Aug;12(4):358-62.</citation>
    <PMID>16901792</PMID>
  </reference>
  <verification_date>November 2013</verification_date>
  <lastchanged_date>November 30, 2015</lastchanged_date>
  <firstreceived_date>August 16, 2010</firstreceived_date>
  <firstreceived_results_date>September 13, 2013</firstreceived_results_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>corticosteroid</keyword>
  <keyword>hyperglycemia</keyword>
  <keyword>hospital</keyword>
  <keyword>corticosteroid induced hyperglycemia in the hospital</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Hyperglycemia</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Glargine</mesh_term>
    <mesh_term>Insulin</mesh_term>
    <mesh_term>Insulin, Globin Zinc</mesh_term>
  </intervention_browse>

  <clinical_results>

    <participant_flow>
      <recruitment_details>Recruitment from May 2011 to August 2012. Location: Hospital.</recruitment_details>
      <group_list>
        <group group_id="P1">
          <title>Experimental Group</title>
          <description>a study-specific steroid NPH dosing algorithm plus standard recommended care</description>
        </group>
        <group group_id="P2">
          <title>Control Group</title>
          <description>the standard recommended care (Methodist Hospital Complete Insulin Orders)</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="35"/>
                <participants group_id="P2" count="37"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="30"/>
                <participants group_id="P2" count="31"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="5"/>
                <participants group_id="P2" count="6"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Experimental Group</title>
          <description>a study-specific steroid NPH dosing algorithm plus standard recommended care</description>
        </group>
        <group group_id="B2">
          <title>Control Group</title>
          <description>the standard recommended care (Methodist Hospital Complete Insulin Orders)</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <measure_list>
        <measure>
          <title>Number of Participants</title>
          <units>participants</units>
          <param>Number</param>
          <category_list>
            <category>
              <measurement_list>
                <measurement group_id="B1" value="35"/>
                <measurement group_id="B2" value="37"/>
                <measurement group_id="B3" value="72"/>
              </measurement_list>
            </category>
          </category_list>
        </measure>
        <measure>
          <title>Age</title>
          <units>participants</units>
          <param>Number</param>
          <category_list>
            <category>
              <sub_title>&lt;=18 years</sub_title>
              <measurement_list>
                <measurement group_id="B1" value="0"/>
                <measurement group_id="B2" value="0"/>
                <measurement group_id="B3" value="0"/>
              </measurement_list>
            </category>
            <category>
              <sub_title>Between 18 and 65 years</sub_title>
              <measurement_list>
                <measurement group_id="B1" value="14"/>
                <measurement group_id="B2" value="18"/>
                <measurement group_id="B3" value="32"/>
              </measurement_list>
            </category>
            <category>
              <sub_title>&gt;=65 years</sub_title>
              <measurement_list>
                <measurement group_id="B1" value="21"/>
                <measurement group_id="B2" value="19"/>
                <measurement group_id="B3" value="40"/>
              </measurement_list>
            </category>
          </category_list>
        </measure>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <category_list>
            <category>
              <measurement_list>
                <measurement group_id="B1" value="67.1" spread="14.2"/>
                <measurement group_id="B2" value="71.6" spread="44.6"/>
                <measurement group_id="B3" value="69.4" spread="33.1"/>
              </measurement_list>
            </category>
          </category_list>
        </measure>
        <measure>
          <title>Gender</title>
          <units>participants</units>
          <param>Number</param>
          <category_list>
            <category>
              <sub_title>Female</sub_title>
              <measurement_list>
                <measurement group_id="B1" value="21"/>
                <measurement group_id="B2" value="24"/>
                <measurement group_id="B3" value="45"/>
              </measurement_list>
            </category>
            <category>
              <sub_title>Male</sub_title>
              <measurement_list>
                <measurement group_id="B1" value="14"/>
                <measurement group_id="B2" value="13"/>
                <measurement group_id="B3" value="27"/>
              </measurement_list>
            </category>
          </category_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <category_list>
            <category>
              <sub_title>United States</sub_title>
              <measurement_list>
                <measurement group_id="B1" value="35"/>
                <measurement group_id="B2" value="37"/>
                <measurement group_id="B3" value="72"/>
              </measurement_list>
            </category>
          </category_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Mean Blood Glucose.</title>
        <description>as stated above</description>
        <time_frame>discharge or until after their 5th day in the hospital</time_frame>
        <safety_issue>No</safety_issue>
        <group_list>
          <group group_id="O1">
            <title>Experimental Group</title>
            <description>a study-specific steroid NPH dosing algorithm plus standard recommended care</description>
          </group>
          <group group_id="O2">
            <title>Control Group</title>
            <description>the standard recommended care (Methodist Hospital Complete Insulin Orders)</description>
          </group>
        </group_list>
        <measure_list>
          <measure>
            <title>Number of Participants</title>
            <units>participants</units>
            <param>Number</param>
            <category_list>
              <category>
                <measurement_list>
                  <measurement group_id="O1" value="30"/>
                  <measurement group_id="O2" value="31"/>
                </measurement_list>
              </category>
            </category_list>
          </measure>
          <measure>
            <title>Mean Blood Glucose.</title>
            <description>as stated above</description>
            <units>mg/dL</units>
            <param>Mean</param>
            <dispersion>Standard Deviation</dispersion>
            <category_list>
              <category>
                <measurement_list>
                  <measurement group_id="O1" value="169.2" spread="36.7"/>
                  <measurement group_id="O2" value="178.3" spread="30.5"/>
                </measurement_list>
              </category>
            </category_list>
          </measure>
        </measure_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>the Mean Blood Glucose of All Blood Glucose Readings</title>
        <description>as stated above</description>
        <time_frame>starting 3 hours after the initial index BG&gt;180 measure, across the entire hospital stay or up through 5 days if hospital LOS is &gt; 5 days</time_frame>
        <safety_issue>No</safety_issue>
      </outcome>
    </outcome_list>

    <reported_events>
      <group_list>
        <group group_id="E1">
          <title>Experimental Group</title>
          <description>a study-specific steroid NPH dosing algorithm plus standard recommended care</description>
        </group>
        <group group_id="E2">
          <title>Control Group</title>
          <description>the standard recommended care (Methodist Hospital Complete Insulin Orders)</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="35"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="37"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>5</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="35"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="37"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>All Principal Investigators ARE employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Dr. Richard Bergenstal</name_or_title>
      <organization>International Diabetes Center</organization>
      <phone>952-993-3796</phone>
      <email>richard.bergenstal@parknicollet.com</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>
